deferoxamine (University of Maryland)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedeferoxamine (University of Maryland)
Drug Alias Namedesferrioxaminedeferoxamine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChelating agents
TargetsUpdating
Therapy Area/IndicationsAnemiaNervous System NeoplasmsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Maryland
Active IndicationsN/A
Inactive IndicationsAnemiaNervous System NeoplasmsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A